paclitaxel has been researched along with Thrombocythemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Janus, M; Lesiak, M; Lukawski, K; Prech, M | 1 |
| Bayram, NA; Bozkurt, E; Durmaz, T; Keleş, T | 1 |
2 other study(ies) available for paclitaxel and Thrombocythemia
| Article | Year |
|---|---|
Thrombocytosis as a potential cause of a very late stent thrombosis in the left main coronary artery.
Topics: Adult; Clopidogrel; Coronary Angiography; Coronary Stenosis; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Out-of-Hospital Cardiac Arrest; Paclitaxel; Thrombocytosis; Ticlopidine; Withholding Treatment | 2013 |
Late stent thrombosis after paclitaxel-eluting stent placement in a patient with essential thrombocytosis.
Topics: Angioplasty, Balloon, Coronary; Coronary Thrombosis; Drug-Eluting Stents; Humans; Male; Middle Aged; Paclitaxel; Risk Factors; Thrombocytosis; Time Factors; Treatment Outcome; Tubulin Modulators | 2010 |